DENAS, GENTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.852
AS - Asia 1.298
EU - Europa 833
SA - Sud America 375
AF - Africa 339
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 20
Totale 6.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.703
SG - Singapore 466
CN - Cina 303
BR - Brasile 248
HK - Hong Kong 131
DE - Germania 119
IT - Italia 87
SE - Svezia 81
FI - Finlandia 78
VN - Vietnam 66
NL - Olanda 49
GB - Regno Unito 44
PL - Polonia 42
RU - Federazione Russa 38
FR - Francia 29
CI - Costa d'Avorio 28
AR - Argentina 26
JP - Giappone 25
BE - Belgio 22
AT - Austria 20
EC - Ecuador 19
IN - India 18
ZA - Sudafrica 18
IQ - Iraq 17
CA - Canada 16
CO - Colombia 16
MX - Messico 16
UA - Ucraina 16
IE - Irlanda 15
TR - Turchia 15
CZ - Repubblica Ceca 13
EG - Egitto 13
ES - Italia 13
RO - Romania 13
VE - Venezuela 13
BA - Bosnia-Erzegovina 12
CY - Cipro 12
MD - Moldavia 12
MG - Madagascar 12
MW - Malawi 12
NP - Nepal 12
PA - Panama 12
PY - Paraguay 12
CM - Camerun 11
DO - Repubblica Dominicana 11
KG - Kirghizistan 11
LA - Repubblica Popolare Democratica del Laos 11
ML - Mali 11
PE - Perù 11
PK - Pakistan 11
SO - Somalia 11
TJ - Tagikistan 11
TW - Taiwan 11
UZ - Uzbekistan 11
BY - Bielorussia 10
CL - Cile 10
CU - Cuba 10
GR - Grecia 10
ID - Indonesia 10
JO - Giordania 10
KZ - Kazakistan 10
MA - Marocco 10
MZ - Mozambico 10
PH - Filippine 10
PT - Portogallo 10
SA - Arabia Saudita 10
SN - Senegal 10
XK - ???statistics.table.value.countryCode.XK??? 10
YE - Yemen 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CH - Svizzera 9
DJ - Gibuti 9
HN - Honduras 9
IL - Israele 9
LB - Libano 9
MY - Malesia 9
UY - Uruguay 9
AM - Armenia 8
AO - Angola 8
BG - Bulgaria 8
BJ - Benin 8
GM - Gambi 8
GN - Guinea 8
GP - Guadalupe 8
JM - Giamaica 8
KE - Kenya 8
TN - Tunisia 8
TZ - Tanzania 8
ZW - Zimbabwe 8
BF - Burkina Faso 7
CV - Capo Verde 7
DZ - Algeria 7
ET - Etiopia 7
GF - Guiana Francese 7
GH - Ghana 7
IS - Islanda 7
NA - Namibia 7
NG - Nigeria 7
PR - Porto Rico 7
Totale 6.450
Salva come PNG Salva come JPEG
Città #
Fairfield 613
Ashburn 410
Woodbridge 319
Chandler 318
Singapore 296
Ann Arbor 243
Houston 238
Cambridge 233
Seattle 195
Wilmington 185
Hong Kong 125
Beijing 107
Santa Clara 76
Boardman 68
San Diego 50
Princeton 48
Munich 46
Medford 45
Des Moines 40
Helsinki 37
Los Angeles 37
Bytom 32
Nanjing 29
Abidjan 28
Dong Ket 27
Frankfurt am Main 25
New York 24
Padova 21
Redondo Beach 18
Roxbury 17
Chicago 13
Dublin 13
Nanchang 12
Panama City 12
Shenyang 12
Bamako 11
Buffalo 11
Vienna 11
Antananarivo 10
Bishkek 10
Brussels 10
Cairo 10
Dakar 10
Dushanbe 10
Guangzhou 10
Johannesburg 10
Tashkent 10
Tokyo 10
Turku 10
Vientiane 10
Amman 9
Baku 9
Hefei 9
London 9
Minsk 9
Pristina 9
Warsaw 9
Baghdad 8
Conakry 8
Dar es Salaam 8
Falkenstein 8
Guayaquil 8
Harare 8
Havana 8
Ho Chi Minh City 8
Maputo 8
Nuremberg 8
Stockholm 8
São Paulo 8
Yerevan 8
Addis Ababa 7
Athens 7
Belo Horizonte 7
Boston 7
Chisinau 7
Cotonou 7
Falls Church 7
Kigali 7
Lilongwe 7
Lima 7
Luanda 7
Montevideo 7
Zhengzhou 7
Bangkok 6
Castries 6
Dearborn 6
Djibouti 6
Douala 6
Gaborone 6
Goiânia 6
Hebei 6
Istanbul 6
Jinan 6
Limassol 6
Milan 6
Phnom Penh 6
Phoenix 6
Praia 6
Redwood City 6
Santiago 6
Totale 4.525
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 244
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 200
Laboratory testing for antiphospholipid syndrome 192
Diagnosis and therapy of antiphospholipid syndrome 191
APS - Diagnostics and challenges for the future 189
Antiphospholipid syndrome and the heart: A case series and literature review 187
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 186
Dyspnoea in a young woman: the opposite of every truth is just as true 179
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 176
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome. 173
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation 171
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns 170
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 169
An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation 165
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 162
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 161
A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures 159
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study 158
The Paradox of the Lupus Anticoagulant: History and Perspectives 157
One-Year Outcomes After Transapical Echocardiography-Guided Mitral Valve Repair 156
Interpretation of laboratory data and need for reference laboratories. 155
An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions 151
The benefit of betrixaban for the extended thromboprophylaxis in acutely ill medical patients 151
Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy 149
Correct laboratory approach to APS diagnosis and monitoring 148
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation 143
Laboratory Diagnostics of Antiphospholipid Syndrome 143
Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective 141
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study 139
Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis 138
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 133
Secondary prevention in thrombotic antiphospholipid syndrome. 131
To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort 129
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study 128
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome: a nationwide survey 127
Reference values for 3D echo parameters describing left ventricular mechanics obtained by vendor-independent software 126
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma 124
Normal left ventricular mechanics by two-dimensional speckle-tracking echocardiography. Reference values in healthy adults 122
Relationship of 3D left ventricular mass with systolic and diastolic function indices in hypertrophic cardiomyopathy 122
Optimizing quality care for the oral vitamin K antagonists (VKAs) 116
Investigational anticoagulants for hematological conditions: a new generation of therapies 116
The role of platelets in antiphospholipid syndrome 113
Reference values of right ventricular longitudinal strain by speckle tracking echocardiography in 219 healthy volunteers 112
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure. 107
Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study 93
Totale 6.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.729
article - articoli 21.729
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021325 0 0 0 0 13 36 23 40 73 24 47 69
2021/2022713 40 70 89 52 17 48 41 80 29 16 59 172
2022/2023557 116 67 15 74 84 63 2 40 53 4 33 6
2023/2024218 7 34 25 22 7 34 14 27 5 5 19 19
2024/20251.170 6 81 72 47 139 14 93 103 83 30 192 310
2025/20261.866 243 374 543 674 32 0 0 0 0 0 0 0
Totale 6.802